Back to search

Article

Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens

2020-05-13

Abstract excerpt

<h4>Background</h4> Several point-of-care (POC) molecular tests have received emergency use authorization (EUA) from the Food and Drug Administration (FDA) for diagnosis of SARS-CoV-2. The test performance characteristics of the Accula (Mesa Biotech) SARS-CoV-2 POC test need to be evaluated to inform its optimal use. <h4>Objectives</h4> The aim of this study was to assess test performance of the Accula SARS-CoV-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
93995ec6-f8b3-5581-a7ec-970ec5ceb65f
DOI
10.1101/2020.05.12.092379
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal SpecimensDOI 10.1101/2020.05.12.092379
Select a neighboring publication to make it the new centre.